시장보고서 | 연간정보서비스 | 맞춤형시장조사 | 메일링 | 샘플 요청 목록
컴퓨터 보조 탐지(CAD) 시장 분석 예측 : 유형, 제품, 서비스, 기술, 용도, 최종 사용자, 구성 요소, 전개, 디바이스(-2034년)
Computer-Aided Detection Market Analysis and Forecast to 2034: Type, Product, Services, Technology, Application, End User, Component, Deployment, Device
상품코드 : 1740648
리서치사 : Global Insight Services LLC
발행일 : 2025년 06월
페이지 정보 : 영문 373 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,750 ￦ 6,690,000
Single User License help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 텍스트의 Copy & Paste 가능하며, 인쇄는 가능합니다.
US $ 5,750 ￦ 8,098,000
Site License help
PDF, Excel 보고서를 동일 기업(국가)의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트의 Copy & Paste 가능합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,750 ￦ 9,507,000
Enterprise License help
PDF, Excel 보고서를 동일 기업의 전 세계 모든분이 이용할 수 있는 라이선스입니다. 텍스트의 Copy & Paste 가능합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


한글목차

컴퓨터 보조 탐지(CAD) 시장은 2024년 8억 5,910만 달러로 평가되었고, 2034년에는 14억 3,970만 달러에 이르고 약 5.3%의 연평균 복합 성장률(CAGR)로 성장할 것으로 예측되고 있습니다. 계기 학습과 화상 처리의 진보에 의해 견인되어 헬스케어에 있어서의 효율적인 진단 툴에 대한 수요의 고조에 대응하고 있습니다.

시장 개요 :

컴퓨터 보조 탐지(CAD)시장은 유방암, 폐암, 대장암, 전립선암, 간암 등으로 구분되며 유방암 CAD가 시장을 선도하고 있습니다. 조기 발견의 중요한 역할에 기인하고 있습니다. 이미지 모달리티와 AI 구동 알고리즘에 있어서의 기술적 진보가, 이 부문의 성장을 한층 더 강화하고 있습니다. 진단의 진보와 환자의 예후를 개선하기 위한 조기 발견에 대한 주목 증가에 의해 견인력을 늘리고 있습니다. 또한 맞춤형 의료와 정밀 진단이 중시되어 특정 암종에 맞는 CAD 솔루션 수요가 높아지고 있어 시장의 신흥 하위 부문의 범위와 영향력이 확대될 가능성이 있습니다.

시장 세분화
유형 유방 조영술, 초음파, 자기 공명 영상(MRI), 토모 합성, 컴퓨터 단층 촬영(CT), X 선 영상 진단
제품 소프트웨어 솔루션, 하드웨어 시스템, 통합 솔루션, 독립형 시스템
서비스 설치 서비스, 교육 및 교육, 유지 보수 및 지원, 컨설팅 서비스
기술 딥러닝, 머신러닝, 인공지능, 패턴 인식, 컴퓨터 비전
용도 유방암, 폐암, 대장암, 전립선암, 간암, 순환기 질환, 신경 질환
최종 사용자 병원, 진단센터, 학술 연구 기관, 전문 클리닉
구성 요소 소프트웨어, 하드웨어
배포 On-Premise, 클라우드 기반
장치 워크스테이션, 모바일 장치

주요 동향과 촉진요인 :

컴퓨터 보조 탐지(CAD) 시장은 주로 의료용 이미지 처리와 인공지능의 기술 진보에 의해 강력한 성장을 이루고 있습니다. 이 혁신은 특히 종양학과 방사선학에서 조기 질병 발견을 크게 개선하여 환자 결과를 개선하고 있습니다. 또 다른 중요한 동향은 의료 의식의 향상과 헬스 케어 인프라의 확대를 배경으로 신흥 시장에서 CAD 시스템의 채택이 증가하고 있다는 것입니다. 규제 당국의 지원과 유리한 상환 정책은 CAD 기술의 채택을 더욱 가속화하고 있습니다. 통합 및 실시간 통찰력과 임상 워크플로우 개선을 제공하는 혁신적인 CAD 솔루션을 개발하는 기업은 비즈니스 기회가 넘쳐나고 있습니다.

주요 억제요인과 도전

컴퓨터 보조 탐지(CAD) 시장에는 몇 가지 중요한 억제요인과 과제가 있습니다. 다양한 도입과 통합의 방해가 되고 있습니다. 또한, 이러한 고도의 시스템을 조작 및 해석할 수 있는 숙련된 전문가의 부족이 현저하고, 그 결과, 충분히 활용되지 않고, 전개가 비효율적으로 되어 있습니다. 요컨대, 윤리적 및 규제적 문제가 발생하기 때문에 데이터 프라이버시에 대한 우려가 상황을 더욱 복잡하게 만들고 있습니다. 마지막으로, 일부 건강 관리 전문가들 사이에는 컴퓨터 보조 탐지(CAD) 기술의 효능과 신뢰성에 대한 회의적인 관점이 뿌리 깊고, 이것이 채택을 늦추고 시장 성장을 방해하고 있습니다.

목차

제1장 컴퓨터 보조 탐지(CAD) 시장 개요

제2장 주요 요약

제3장 시장에 관한 중요 인사이트

제4장 컴퓨터 보조 탐지(CAD) 시장 전망

제5장 컴퓨터 보조 탐지(CAD) 시장 전략

제6장 컴퓨터 보조 탐지(CAD) 시장 규모

제7장 컴퓨터 보조 탐지(CAD) 시장 : 유형별

제8장 컴퓨터 보조 탐지(CAD) 시장 : 제품별

제9장 컴퓨터 보조 탐지(CAD) 시장 : 서비스별

제10장 컴퓨터 보조 탐지(CAD) 시장 : 테크놀로지별

제11장 컴퓨터 보조 탐지(CAD) 시장 : 용도별

제12장 컴퓨터 보조 탐지(CAD) 시장 : 최종 사용자별

제13장 컴퓨터 보조 탐지(CAD) 시장 : 구성 요소별

제14장 컴퓨터 보조 탐지(CAD) 시장 : 전개별

제15장 컴퓨터 보조 탐지(CAD) 시장 : 디바이스별

제16장 컴퓨터 보조 탐지(CAD) 시장 : 지역별

제17장 경쟁 구도

제18장 기업 프로파일

SHW
영문 목차

영문목차

Computer-Aided Detection Market is anticipated to expand from $859.1 million in 2024 to $1,439.7 million by 2034, growing at a CAGR of approximately 5.3%. The market encompasses technologies designed to assist radiologists in interpreting medical images, enhancing diagnostic accuracy through automated anomaly detection. This market is driven by advancements in machine learning and image processing, addressing the increasing demand for efficient diagnostic tools in healthcare. Emphasizing early disease detection, it supports diverse applications, including oncology, cardiology, and neurology, while fostering innovations in algorithm development and integration with existing medical imaging systems.

Market Overview:

The Computer-Aided Detection (CAD) Market is segmented into breast cancer, lung cancer, colorectal cancer, prostate cancer, liver cancer, and others, with breast cancer CAD leading the market. This dominance is attributed to the high prevalence of breast cancer, increasing awareness, and the critical role of early detection in improving survival rates. Technological advancements in imaging modalities and AI-driven algorithms further bolster this segment's growth. Lung cancer CAD is an emerging sub-segment, gaining traction due to advancements in CT imaging and an increasing focus on early detection to improve patient outcomes. The integration of AI and machine learning in CAD systems is revolutionizing diagnostic accuracy and efficiency, enhancing their adoption across healthcare facilities. Furthermore, the growing emphasis on personalized medicine and precision diagnostics is driving demand for CAD solutions tailored to specific cancer types, potentially expanding the scope and impact of emerging sub-segments in the market.

Market Segmentation
TypeMammography, Ultrasound, Magnetic Resonance Imaging (MRI), Tomosynthesis, Computed Tomography (CT), X-ray Imaging
ProductSoftware Solutions, Hardware Systems, Integrated Solutions, Stand-alone Systems
ServicesInstallation Services, Training and Education, Maintenance and Support, Consulting Services
TechnologyDeep Learning, Machine Learning, Artificial Intelligence, Pattern Recognition, Computer Vision
ApplicationBreast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Liver Cancer, Cardiovascular Diseases, Neurological Disorders
End UserHospitals, Diagnostic Centers, Academic and Research Institutes, Specialty Clinics
ComponentSoftware, Hardware
DeploymentOn-premise, Cloud-based
DeviceWorkstations, Mobile Devices

Geographical Overview:

The Computer-Aided Detection (CAD) market showcases varying growth trajectories across different regions. North America dominates this market, driven by technological advancements and a high prevalence of chronic diseases. The region's robust healthcare infrastructure and increasing adoption of CAD systems in diagnostic imaging further propel growth. Europe follows closely, with significant investments in healthcare technology and a strong focus on early disease detection. The region's regulatory support and increasing awareness about the benefits of CAD systems contribute to its market expansion. In the Asia Pacific, the CAD market is rapidly growing. This expansion is fueled by rising healthcare expenditures and increasing adoption of advanced diagnostic tools. Governments in the region are investing in healthcare infrastructure, further supporting market growth. Latin America presents a burgeoning market for CAD systems. The region is experiencing an increasing demand for advanced diagnostic solutions, driven by a growing healthcare sector and rising disease prevalence. The Middle East & Africa are also emerging markets for CAD. There is a growing recognition of the importance of early disease detection and the adoption of advanced healthcare technologies. Investments in healthcare infrastructure are expected to drive market growth in these regions.

Recent Developments:

The Computer-Aided Detection (CAD) market has experienced notable developments over the past three months. Siemens Healthineers announced a strategic partnership with a leading AI firm to enhance its CAD capabilities, aiming to integrate advanced AI algorithms into their detection systems. In a landmark merger, Philips acquired a prominent CAD startup, seeking to bolster its diagnostic imaging portfolio and accelerate innovation in automated detection technologies. GE Healthcare unveiled a new CAD software suite designed to improve early disease detection, highlighting their commitment to leveraging AI for better healthcare outcomes. Regulatory advancements were also observed, with the FDA granting clearance to a novel CAD system that employs deep learning for breast cancer detection, marking a significant step forward in regulatory acceptance of AI-driven solutions. Furthermore, a recent market analysis report predicts a robust growth trajectory for the CAD market, driven by increased adoption in emerging economies and technological advancements, underscoring lucrative opportunities for stakeholders.

Key Companies:

i CAD, Hologic, Zebra Medical Vision, Riverain Technologies, Median Technologies, Screen Point Medical, Qure.ai, Infervision, Aidoc, Therapixel, Oxipit, Lunit, Cure Metrix, Vuno, Koios Medical, Deep Tek, Qlarity Imaging, Behold.ai, Rad Logics, Volpara Health Technologies

Key Trends and Drivers:

The Computer-Aided Detection (CAD) market is experiencing robust growth, primarily driven by technological advancements in medical imaging and artificial intelligence. Key trends include the integration of machine learning algorithms that enhance diagnostic accuracy and reduce false positives. This innovation is significantly improving early disease detection, particularly in oncology and radiology, leading to better patient outcomes. Another pivotal trend is the increasing adoption of CAD systems in emerging markets, driven by rising healthcare awareness and expanding healthcare infrastructure. The demand for non-invasive diagnostic tools is also propelling market growth, as patients and providers seek safer, more efficient diagnostic options. Regulatory support and favorable reimbursement policies are further accelerating the adoption of CAD technologies. Moreover, the trend towards personalized medicine is driving the need for advanced diagnostic tools, including CAD systems, to tailor treatments to individual patient needs. Opportunities abound for companies developing innovative CAD solutions that integrate seamlessly with existing healthcare systems, offering real-time insights and improved clinical workflows. As the global healthcare landscape evolves, the CAD market is poised for sustained expansion, driven by a confluence of technological, regulatory, and consumer-driven forces.

Key Restraints and Challenges:

The Computer-Aided Detection Market encounters several significant restraints and challenges. A predominant challenge is the high cost of sophisticated detection systems, which limits their accessibility for smaller healthcare facilities and developing regions. This financial barrier hinders widespread adoption and integration into existing healthcare frameworks. Additionally, there is a notable shortage of skilled professionals capable of operating and interpreting these advanced systems, leading to underutilization and inefficiencies in deployment. Data privacy concerns further complicate the landscape, as the integration of AI and machine learning necessitates the handling of sensitive patient data, raising ethical and regulatory issues. The market also grapples with technological interoperability challenges, as varying software and hardware systems struggle to communicate effectively, impeding seamless integration. Finally, there is a persistent skepticism among some healthcare professionals regarding the efficacy and reliability of computer-aided detection technologies, which can slow adoption and hinder market growth. These challenges collectively pose significant hurdles to the market's expansion.

Sources:

World Health Organization (WHO), National Institutes of Health (NIH), U.S. Food and Drug Administration (FDA), European Medicines Agency (EMA), International Society for Optics and Photonics (SPIE) Medical Imaging Conference, Radiological Society of North America (RSNA) Annual Meeting, European Congress of Radiology (ECR), American College of Radiology (ACR), International Society for Magnetic Resonance in Medicine (ISMRM), American Association of Physicists in Medicine (AAPM), World Congress of Medical Physics and Biomedical Engineering, International Conference on Medical Image Computing and Computer-Assisted Intervention (MICCAI), Institute of Electrical and Electronics Engineers (IEEE) - Engineering in Medicine and Biology Society, National Cancer Institute (NCI), European Society for Radiotherapy and Oncology (ESTRO), World Health Assembly (WHA), International Atomic Energy Agency (IAEA) - Human Health Division, Mayo Clinic - Department of Radiology, Johns Hopkins University - Department of Biomedical Engineering, Massachusetts General Hospital - Center for Clinical Data Science

Research Scope:

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1: Computer-Aided Detection Market Overview

2: Executive Summary

3: Premium Insights on the Market

4: Computer-Aided Detection Market Outlook

5: Computer-Aided Detection Computer-Aided Detection Market Strategy

6: Computer-Aided Detection Market Size

7: Computer-Aided Detection Market, by Type

8: Computer-Aided Detection Market, by Product

9: Computer-Aided Detection Market, by Services

10: Computer-Aided Detection Market, by Technology

11: Computer-Aided Detection Market, by Application

12: Computer-Aided Detection Market, by End User

13: Computer-Aided Detection Market, by Component

14: Computer-Aided Detection Market, by Deployment

15: Computer-Aided Detection Market, by Device

16: Computer-Aided Detection Market, by Region

17: Competitive Landscape

18: Company Profiles

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기